Veracyte, Inc. (VCYT)

19,31 -0,17 (-0,87%) Al cierre: 04:00PM EDT

Veracyte, Inc.

6000 Shoreline Court
Suite 300
South San Francisco, CA 94080
United States
650 243 6300
https://www.veracyte.com

Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 815

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Marc A. Stapley	CEO & Director	1,55M	N/A	1970
Ms. Rebecca Chambers	Executive VP & CFO	901,49k	N/A	1978
Dr. Phillip G. Febbo M.D.	Chief Scientific & Medical Officer	657,74k	N/A	1966
Ms. Annie McGuire	Executive VP, General Counsel & Chief People Officer	791,72k	N/A	1981
Dr. John Leite Ph.D.	Chief Commercial Officer for CLIA Business	1,53M	N/A	1972
Mr. Jonathan Wygant	VP & Chief Accounting Officer	N/A	N/A	1971
Mr. Steven French	Senior VP & Chief Information Officer	N/A	N/A	N/A
Ms. Karen Possemato	Senior Vice President of Corporate Marketing, Communications & Commercial Operations	N/A	N/A	N/A
Mr. Robert Brainin	Executive VP & Chief Business Officer	N/A	N/A	1971
Ms. Corinne Danan	Senior Vice President	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Gobierno corporativo

El ISS Governance QualityScore de Veracyte, Inc., a día 1 de abril de 2024, es 4. Las puntuaciones base son Auditoría: 5; Tablero: 2; Derechos de los accionistas: 4; Compensación: 7.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.